Get started
Author

Ademola Oluwatosin Oyekan

Observed names: A. Oyekan, Ademola O. Oyekan, Ademola Oyekan, Oyekan Ademola, Oyekan, Ademola
ORCID: 0009-0001-1156-2346
Observed ORCID: 0009-0001-1156-2346
OpenAlex ID: A5056352129
Distribution of Breast Cancer Subtypes Among Nigerian Women and Correlation to the Risk Factors and Clinicopathological Characteristics
2020 · Adeoluwa Akeem Adeniji, Olayemi Olubunmi Dawodu, et al. · World Journal of Oncology · 43
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients
2025 · Abimbola F. Onyia, Paul Jibrin, et al. · Technology in Cancer Research & Treatment · 8
A systematic review of endometrial cancer clinical research in Africa
2024 · Chidinma P. Anakwenze, Agnes Ewongwo, et al. · Infectious Agents and Cancer · 8
PDF
Prevalence and predictors of chemotherapy-induced peripheral neuropathy among female breast cancer patients undergoing chemotherapy in Lagos
2024 · Ademola Oluwatosin Oyekan, Omolara Aminat Fatiregun, et al. · ecancermedicalscience · 6
Health literacy and breast cancer preventive practices among market women in Oshodi Local Government Area of Lagos State, Nigeria
2024 · Omolara Aminat Fatiregun, Yetunde Kuyinu, et al. · ecancermedicalscience · 3
Association between CYP17A1 and HSD3B1 gene polymorphisms and testosterone levels in Nigerian prostate cancer patients
2025 · Christogonus Chichebe Ekenwaneze, Suleiman Zakari, et al. · Scientific Reports · 2
PDF
1 H NMR-Based Plasma Metabolomics and Machine Learning Reveal Distinct Metabolic Signatures of Breast Cancer in Nigerian Women
2026 · Abimbola F. Onyia, Olutola E. Olasehinde, et al. · Journal of Proteome Research · 1
Radiation therapy in breast cancer patients in south west Nigeria: an evaluation of protocols in a specialist cancer centre
2026 · Adewumi Alabi, Francis Boateng, et al. · BMC Cancer
Survival and Quality of Life in Patients With Brain Metastasis After Palliative Radiotherapy to the Brain in Lagos State, Nigeria
2026 · Ademola Oyekan, Omolara Fatiregun, et al. · Nigerian Journal of Oncology
PDF
BRCA1 rs799917 and rs1799966 Variants and Breast Cancer Risk in Nigerian Women: A Case–Control Study With Population-Based Allele Frequency Analysis
2026 · Ogunniyi B. Oluwabusayo, Abimbola F. Onyia, et al. · Cancer Control
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (ARETTA)
2026 · Atara Ntekim, Abiodun Popoola, et al. · JCO Global Oncology
Tissue polypeptide specific antigen and cancer antigen-15.3 as predictive biomarkers for metastasis in breast cancer
2026 · Omobolanle T. Akinbami, Anthonia C. Sowunmi, et al. · International Journal of Scientific Reports
PDF
Abstract 999: Spectrum of germline BRCA1/2 gene mutations in Nigerian breast cancer patients
2025 · Abimbola F. Onyia, Paul Jibrin, et al. · Cancer Research
Author response for "Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients"
2025 · Abimbola F. Onyia, Paul Jibrin, et al.
Author response for "Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients"
2025 · Abimbola F. Onyia, Paul Jibrin, et al.
Author response for "Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients"
2024 · Abimbola F. Onyia, Paul Jibrin, et al.
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Taxotere and Trastuzumab in Nigerian Women with Her2-Positive Breast Cancer (ARETTA): First Report from the Nigerian Breast Cancer Study Group
2024 · Atara Ntekim, Abiodun Popoola, et al. · SSRN Electronic Journal
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria
2022 · O.A. Alabi, W. Swanson, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 20
Citation count: 71
H-index: 4
I10-index: 1
Year
Topic
Type